Boehringer Offers 92% Discount On Adalimumab Via GoodRx
Chris Marsh, Boehringer’s SVP Of Value And Access, Discusses Deal For Humira Biosimilar
Boehringer Ingelheim is partnering with GoodRx in the US to offer a version of its Humira biosimilar at a 92% discount to the brand’s list price. Generics Bulletin spoke with Chris Marsh, Boehringer’s senior vice president of value and access, about the initiative.
